Fund moves

Avantor (AVTR): Gendell Jeffrey L added to its stake +4.37M shares

Gendell Jeffrey L added to its stake in Avantor, per its Q1 2026 13F.

4.92M
Shares reported · +4.37M vs prior quarter
0.53%
Disclosed portfolio weight
$38.6M
Reported value
Holdings as of
Mar 31, 2026
Filed
May 15, 2026

What stands out in this filing

  • 545,000 shares in Q4 2025, 4,917,270 now (+802.3% in share count).
  • Reported at $38.6M, 0.53% of the portfolio value in this 13F filing.
  • 11 other tracked managers reported the same kind of change for Q1 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 26, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 26, 2026, Mr. R. Brent Jones notified Avantor, Inc. (the “Company”) of his decision to resign as the Company’s Executive Vice President and Chief Financial Officer (“CFO”) to join a company outside the life sciences industry.”
  2. Apr 17, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 17, 2026, Avantor, Inc. (the “Company”) informed Benoit Gourdier, the Company’s Executive Vice President, Bioscience and Medtech Products, that he would be transitioning to a new role supporting the Company’s segment integration activities, after which it is expected that he would depart the Company no later than December 31, 2026.”
  3. Apr 17, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 23, 2026, Avantor, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original 8-K”) disclosing that Benoit Gourdier, the Company’s Executive Vice President, Bioscience and Medtech Products, would transition to a new role supporting the Company’s segment integration activities for a period of time, after which he would depart the Company.”
  4. Apr 29, 2026Company filing · Form 8-K · ResultsReported its results
  5. May 1, 2026Insider · Their first buy on recordDirector purchased ~$204K of AVTR shares in the open market
  6. May 8, 2026InsiderDirector purchased ~$83K of AVTR shares in the open market

What came next

  1. Jul 14, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  2. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
  3. Aug 3, 2026Federal contract · $96K obligatedDepartment of Health and Human Services awarded Avantor, Inc.: $96K obligated to date
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Avantor

For Avantor, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AVTR page.

How this filing works

Explore the data

Common questions

What does this filing report about Avantor (AVTR) stock?

Gendell Jeffrey L added to its stake in Avantor, per its Q1 2026 13F. Now 4.92M shares, $38.6M reported value, 0.53% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: May 15, 2026.

What stands out in this filing?

545,000 shares in Q4 2025, 4,917,270 now (+802.3% in share count). Reported at $38.6M, 0.53% of the portfolio value in this 13F filing. 11 other tracked managers reported the same kind of change for Q1 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Avantor recently?

For Avantor, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the AVTR page.

Does this mean AVTR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Avantor

Everything OQRO holds on this company is on its AVTR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data